Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092482
Status:
COMPLETED
Last Update Posted:
2017-03-22
First Post:
2004-09-22
Brief Title:
Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil V501 a Quadrivalent Vaccine V501-012COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2004-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-22
First Submit QC Date:
September 24 2004
Study First Post Date:
2004-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-20
Last Update Post Date:
2017-03-22
Last Update Post Date Type:
ACTUAL